Article Text

PDF
Initial poor quality of life and new onset of dyspepsia: results from a longitudinal 10-year follow-up study
  1. Alexander C Ford1,
  2. David Forman2,
  3. Alastair G Bailey1,
  4. Anthony T R Axon1,
  5. Paul Moayyedi2
  1. 1Centre for Digestive Diseases, Leeds General Infirmary, Leeds, UK
  2. 2Centre for Epidemiology and Biostatistics, Medical School, Leeds University, Leeds, UK
  3. 3Gastroenterology Division, McMaster University, Health Sciences Centre, Hamilton, Ontario, Canada
  1. Correspondence to:
    Dr A C Ford
    Room 7.23, Department of Academic Medicine, Clinical Sciences Building, St James’s University Hospital, Leeds LS9 7TF, UK;alexf12399{at}yahoo.com

Abstract

Background: Numerous studies examining the prevalence and natural history of dyspepsia in the general population have been conducted. However, few have reported the effect of quality of life on the development of dyspepsia. A 10-year longitudinal follow-up study examining the effect of quality of life on subsequent dyspepsia was performed.

Methods: Individuals originally enrolled in a population-screening programme for Helicobacter pylori were contacted through a validated postal dyspepsia questionnaire. Baseline demographic data, quality of life at original study entry, and dyspepsia and irritable bowel syndrome (IBS) symptom data were already on file. Consent to examine primary-care records was sought, and data regarding non-steroidal anti-inflammatory drugs (NSAID) and aspirin use were obtained from these.

Results: Of 8407 individuals originally involved, 3912 (46.5%) provided symptom data at baseline and 10-year follow-up. Of 2550 (65%) individuals asymptomatic at study entry, 717 (28%) developed new-onset dyspepsia at 10 years, an incidence of 2.8% per year. After multivariate logistic regression, lower quality of life at study entry (OR 2.63; 99% CI 1.86 to 3.71), higher body mass index (OR per unit 1.05; 99% CI 1.02 to 1.08), presence of IBS at study entry (OR 3.1; 99% CI 1.51 to 6.37) and use of NSAIDs and/or aspirin (OR 1.32; 99% CI 0.99 to 1.75) were significant risk factors for new-onset dyspepsia.

Conclusions: The incidence of new-onset dyspepsia was almost 3% per year. Low quality of life at baseline exerted a strong effect on the likelihood of developing dyspepsia at 10 years.

  • BMI, body mass index
  • BSG, British Society of Gastroenterology
  • IBS, irritable bowel syndrome
  • LDQ, Leeds Dyspepsia Questionnaire
  • NSAID, non-steroidal anti-inflammatory drug
  • PAR%, population attributable risk percentage
  • PGWBI, Psychological and General Well-Being Index
  • S-FLDQ, Short-Form Leeds Dyspepsia Questionnaire

Statistics from Altmetric.com

Footnotes

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Digest
    Emad El-Omar